Metraipolis › archive › dc_bcf7e8f40922
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond — Europe PMC PMID:41374935
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41374935
- DOI
- 10.3390/cancers17233733
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T09:15:56.890Z
- SHA-256 of the archived text
39664fdc6cd79cf7364e8f4430b890075d4ceaf8378e6d78c2e41bf713773c9a- Stable URL of this page
https://metraipolis.com/documento/dc_bcf7e8f40922
How to cite
Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond — Europe PMC PMID:41374935 — Europe PMC (en), https://europepmc.org/article/MED/41374935 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcf7e8f40922 (Metraipolis archive dc_bcf7e8f40922, sha256 39664fdc6cd79cf7364e8f4430b890075d4ceaf8378e6d78c2e41bf713773c9a)
BibTeX
@misc{dcbcf7e8f40922,
title = {Harnessing Venetoclax in NPM1-Mutated AML: A Path to Sustained Remission and Beyond — Europe PMC PMID:41374935},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41374935},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcf7e8f40922; sha256 39664fdc6cd79cf7364e8f4430b890075d4ceaf8378e6d78c2e41bf713773c9a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41374935. Agents can read the archived copy with the MCP tool read_document.